Mannitol Baxter Holding

Mannitol, the active ingredient in Mannitol Baxter Holding, is an osmotic diuretic presented as an intravenous solution for intravenous use. It creates an osmotic gradient that helps lower intracranial and intraocular pressure and promotes renal excretion of water and electrolytes in patients with acute kidney injury or during certain surgeries.

GNH USA supplies Mannitol Baxter Holding as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mannitol acts as an osmotic diuretic to manage fluid shifts in several clinical situations.

- Elevated intracranial pressure: reduces brain swelling by drawing water from cerebral tissue into the vascular compartment. - Acute renal failure: promotes diuresis to assist renal clearance of waste products. - Intraocular pressure elevation: lowers eye pressure in glaucoma or ocular surgery settings. - Surgical renal protection: safeguards kidney function during procedures that risk ischemic injury.

Mannitol may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea or vomiting: gastrointestinal upset. - Electrolyte imbalance: especially hyponatremia or hyperkalemia. - Transient hypotension: due to rapid plasma volume expansion. - Flank pain: related to increased renal flow. - Thirst or dry mouth.

Serious or Rare Side Effects: - Acute renal failure: paradoxical worsening of kidney function. - Pulmonary edema: fluid overload in susceptible patients. - Severe electrolyte disturbances: leading to cardiac arrhythmias. - Hemolysis: in patients with G6PD deficiency. - Allergic reactions: rash, urticaria, or anaphylaxis. - Metabolic acidosis: from excessive acid load.

Mannitol should be used with careful clinical monitoring.

- Renal function assessment: avoid in patients with established renal failure unless benefits outweigh risks. - Fluid balance monitoring: watch for signs of overload or dehydration. - Electrolyte surveillance: correct abnormalities before and during therapy. - Cardiovascular status: use cautiously in patients with heart failure or unstable hemodynamics. - Pregnancy and lactation: safety not established; weigh potential benefits against unknown risks. - Store at ambient temperature: keep in original container, protect from light and moisture.

Mannitol can interact with several medications, requiring vigilance.

Major Interactions (Avoid): - Loop diuretics (e.g., furosemide): may exacerbate electrolyte loss and volume depletion. - Nephrotoxic agents (e.g., aminoglycosides, amphotericin B): increase risk of renal injury. - Insulin or oral hypoglycemics: osmotic shifts may affect glucose control.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood pressure lowering effects. - Anticoagulants: altered plasma volume may affect drug concentrations. - CNS depressants: enhanced sedation if intracranial pressure changes rapidly.